The veterinary pharmaceuticals firm Dechra has revealed growing sales across all its major brands and profits ahead of market forecasts for the full year to the end of June.
Group revenue to the end of June increased by 9.5% compared to 2011, from £389.2m to £426m. That figure is also ahead of market expectations of £420.2m. Dechra says 7.9% of this growth was organic whilst 1.8% was contributed by the acquisition of Dutch rival Eurovet. Currency movements had a negative impact of 0.2%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
1,000 children hold over £100,000 in a junior ISA – how to grow tax-free nest egg for your childJunior ISAs can be a tax-efficient way to grow a nest egg for your child. We explain how they work
-
How to start investing: a beginner’s guideGetting started in investing is a great way to make your money work harder for you over the long term, as investments tend to outperform cash savings
